bicalutamide has been researched along with Prostatic Intraepithelial Neoplasia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argusti, A; Bandelloni, R; Branchi, D; Campodonico, F; Decensi, A; Maffezzini, M; Montironi, R; Mori, M; Puntoni, M; Turbino, L; Zanardi, S | 1 |
| Bedolla, RG; Ghosh, PM; Kreisberg, JI; Malik, SN; Mikhailova, M; Prihoda, TJ; Troyer, DA; Wang, Y | 1 |
| Akaza, H; Ideyama, Y; Kawai, K; Shirai, T; Tsukamoto, S; Yamauchi, A | 1 |
| Bono, AV; Cheng, L; Ferrari, I; Galosi, AB; Lopez-Beltran, A; Mazzucchelli, R; Montironi, R | 1 |
| Freschi, M; Losa, A; Mazzucchelli, R; Montironi, R; Montorsi, F; Nava, L; Pappagallo, G; Rigatti, P; Scarpa, RM; Scattoni, V; Terrone, C | 1 |
| Biagini, G; Lucarini, G; Mazzucchelli, R; Montironi, R; Pugnaloni, A; Santinelli, A | 1 |
3 trial(s) available for bicalutamide and Prostatic Intraepithelial Neoplasia
| Article | Year |
|---|---|
Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Biopsy; Dose-Response Relationship, Drug; Gynecomastia; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tosyl Compounds | 2009 |
Bicalutamide 50 mg monotherapy in patients with isolated high-grade PIN: findings in repeat biopsies at 6 months.
Topics: Aged; Anilides; Antineoplastic Agents; Biopsy; Follow-Up Studies; Humans; Male; Middle Aged; Nitriles; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2007 |
Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Humans; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2006 |
3 other study(ies) available for bicalutamide and Prostatic Intraepithelial Neoplasia
| Article | Year |
|---|---|
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Antibiotics, Antineoplastic; Cell Proliferation; Enzyme Inhibitors; Humans; Ki-67 Antigen; Male; Mitogen-Activated Protein Kinases; Neoplasms, Hormone-Dependent; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tosyl Compounds; Tumor Cells, Cultured | 2005 |
Persistence of prostatic intraepithelial neoplasia after effective chemoprevention of microscopic prostate cancer with antiandrogen in a rat model.
Topics: Aminobiphenyl Compounds; Androgen Antagonists; Anilides; Animals; Carcinogens; Disease Models, Animal; Male; Neoplasms, Experimental; Nitriles; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Rats; Rats, Inbred F344; Tosyl Compounds | 2006 |
Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Endothelial Growth Factors; Goserelin; Humans; Immunohistochemistry; Lymphokines; Male; Middle Aged; Neovascularization, Pathologic; Nitriles; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tosyl Compounds; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |